HealthQuest Capital has announced it has raised $110 million for its debut fund.
HealthQuest Capital (HQC) is a Menlo Park, Calif.-based fund sponsored by Sofinnova Ventures.
HQC indicated it will focus investments in the medical device, diagnostics, patient care products, consumer health/OTC and healthcare IT fields, with a primary focus on commercial stage investments, providing capital towards growing revenues and scaling existing businesses in promising sectors.
HQC’s initial portfolio includes Vestagen, First Aid Shot Therapy and Castle Biosciences.